Pfizer COVID-19 Antiviral Pill Could Be Ready By The End of This Year
162Shares Pfizer’s new oral antiviral treatment for COVID-19 could be made available by the end of this year according to its Chairman and CEO, Albert Bourla. The American pharma company has already begun the Phase 1 trial for the antiviral treatment in the United States since early this year. ADVERTISEMENT Speaking to CNBC’s Squawk Box, Albert pointed out that the oral medication which is currently being designated as antiviral candidate PF-07321332 could be used at home. This is unlike the traditional vaccine injection which needs to be administered at a hospital or a specially designat...